STAND. COM. REP. NO. 3141

Honolulu, Hawaii

RE: S.B. No. 2993

Honorable Ronald D. Kouchi

President of the Senate

Thirtieth State Legislature

Regular Session of 2020

State of Hawaii

Sir:

Your Committee on Judiciary, to which was referred S.B. No. 2993 entitled:

"A BILL FOR AN ACT RELATING TO COMMERCIAL DRIVER'S LICENSES,"

begs leave to report as follows:

The purpose and intent of this measure is to align the State's commercial driver's license qualification standards with federal regulations by repealing language related to medical waivers due to diabetes.

Your Committee received testimony in support of this measure from the Department of Transportation.

Your Committee finds that an amendment to a federal rule removed the requirement for commercial driver's license holders who are treating diabetes with insulin to obtain a medical waiver in addition to their periodic medical examination. Rather than continue to require a waiver, the medical examiner who examines the driver using insulin will confer with the driver's treating clinician, evaluates the driver's medical records, and decide whether the driver's medical condition will have an adverse effect on the driver's ability to drive safely. If the driver satisfies the medical requirements, a medical examiner's certificate with no indication of a waiver is issued to the driver. This measure aligns state law with federal regulations and expedites the certification process for commercial driver's license holders who are treating diabetes with insulin.

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2993 and recommends that it pass Third Reading.

Respectfully submitted on behalf of the members of the Committee on Judiciary,

________________________________

KARL RHOADS, Chair